Cancer MoonShot 2020, NantHealth Target Breast Cancer

Culver City-based CancerMoonShot 2020, and NantHealth said this morning that the two are taking aim at Inflammatory Breast Cancer, with a new working group focused on the disease. According to Cancer MoonShot 2020, the team includes physicians, researchers and oncology professors from across the nation, to investigate personalized, immunotherapeutic treament options for the rare disease, which is the deadliest form of breast cancer. The new group will use NantHealth's comprehensive "GPS Cancer" testing offerings, which uses proteomics, whole genome (DNA and RNA) testing, and other technology to provide a molecular profile of a patient's cancer. Cancer MoonShot 2020 has formed a number of different working groups focused on specific forms of cancer.